Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cardiology Reviews
  4. Volume 21, Issue 1
  5. Article
Volume 21, Issue 1
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Background

Acute Heart Failure (HF) is related to a significant hospital mortality rate and functional impairment in many patients. However, there is still a lack of studies that support the use of Beta-blockers (BB) in the management of decompensated HF. Objective: This study aimed to evaluate the impact on mortality of maintaining BB in patients with decompensated HF.

Methods

A systematic review and meta-analysis was performed, using the databases PubMed, Cochrane Library, SCIELO and BVS, selecting only cohort studies and Randomized Clinical Trials (RCTs) from the last 10 years, which have been selected based on inclusion and exclusion criteria.

Results

An 86% reduction in the risk of in-hospital death was found (RR=0.14, 95% CI: 0.10-0.18) in patients with HF who maintained the use of BB during hospitalization. A second analysis found a 44% (RR=0.56, 95% CI: 0.47-0.66) lower chance of in-hospital death in the group that previously used BB. Regarding the analysis of mortality after hospital discharge, only studies that have evaluated the use of BB in HF with reduced ejection fraction pointed to a reduction in mortality. Furthermore, some articles have found a relationship between the reduction in readmissions and the use of post-discharge BB.

Conclusion

There is still no consensus regarding the use of BB in patients hospitalized with decompensated HF. In view of the limitations of the data found in the present study, the need for more RCTs that address this topic is emphasized in order to resolve this uncertainty in the management of cardiovascular patients.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X291307240902071924
2024-09-16
2025-05-22

  • From This Site

    /content/journals/ccr/10.2174/011573403X291307240902071924
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. McDonaghT.A. MetraM. AdamoM. Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (esc) with the special contribution of the heart failure association (HFA) of the ESC.Eur. Heart J.202142363599372610.1093/eurheartj/ehab368 34447992
     [Google Scholar]
  2. ChioncelO. MebazaaA. MaggioniA.P. Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry.Eur. J. Heart Fail.201921111338135210.1002/ejhf.1492 31127678
     [Google Scholar]
  3. TomasoniD. LombardiC.M. SbolliM. CotterG. MetraM. Acute heart failure: More questions than answers.Prog. Cardiovasc. Dis.202063559960610.1016/j.pcad.2020.04.007 32283133
     [Google Scholar]
  4. ArrigoM. JessupM. MullensW. Acute heart failure.Nat. Rev. Dis. Primers2020611610.1038/s41572‑020‑0151‑7 32139695
     [Google Scholar]
  5. SilvaW.T. TyllM.G. MirandaA.C. Clinical characteristics and comorbidities associated with heart failure mortality in a highly complex hospital in the Amazon Region of Brazil.2020Available from: http://scielo.iec.gov.br/pdf/rpas/v11/2176-6223-rpas-11-e202000449.pdf
    [Google Scholar]
  6. SinnenbergL. GivertzM.M. Acute heart failure.Trends Cardiovasc. Med.202030210411210.1016/j.tcm.2019.03.007 31006522
     [Google Scholar]
  7. NjorogeJ.N. TeerlinkJ.R. Pathophysiology and therapeutic approaches to acute decompensated heart failure.Circ. Res.2021128101468148610.1161/CIRCRESAHA.121.318186 33983837
     [Google Scholar]
  8. RohdeL.E.P. MonteraM.W. BocchiE.A. Diretriz brasileira de insuficiência cardíaca crônica e aguda.Arq. Bras. Cardiol.2018111343653910.5935/abc.20180190 30379264
     [Google Scholar]
  9. FelkerG.M. EllisonD.H. MullensW. CoxZ.L. TestaniJ.M. Diuretic therapy for patients with heart failure: JACC state-of-the-art review.J. Am. Coll. Cardiol.202075101178119510.1016/j.jacc.2019.12.059 32164892
     [Google Scholar]
  10. AgostoniP. FarmakisD.T. García-PinillaJ.M. Haemodynamic balance in acute and advanced heart failure: An expert perspective on the role of levosimendan.Card. Fail. Rev.20195315516110.15420/cfr.2019.01.R1 31768272
     [Google Scholar]
  11. PrinsK.W. NeillJ.M. TylerJ.O. EckmanP.M. DuvalS. Effects of beta-blocker withdrawal in acute decompensated heart failure.JACC Heart Fail.20153864765310.1016/j.jchf.2015.03.008 26251094
     [Google Scholar]
  12. HeidenreichP.A. BozkurtB. AguilarD. AHA/ACC/HFSA guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines.J. Am. Coll. Cardiol.2022791726342110.1016/j.jacc.2021.12.012
     [Google Scholar]
  13. KhalilC. SuwaidiJ. SinghR. Beta-blockers are associated with decreased in-hospital mortality and stroke in acute decompensated heart failure: Findings from a retrospective analysis of a 22-year registry in the Middle East (1991-2013).Curr. Vasc. Pharmacol.2016151778310.2174/1570161114666160822155440 27550053
     [Google Scholar]
  14. MebazaaA. DavisonB. ChioncelO. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial.Lancet2022400103671938195210.1016/S0140‑6736(22)02076‑1 36356631
     [Google Scholar]
  15. McDonaghT.A. MetraM. AdamoM. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur. Heart J.202344373627363910.1093/eurheartj/ehad195 37622666
     [Google Scholar]
  16. SterneJ.A. SavovićJ. PageM.J. RoB 2: A revised tool for assessing risk of bias in randomised trials.BMJ2019366l489810.1136/bmj.l4898 31462531
     [Google Scholar]
  17. WellsG.A. SheaB. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.2021Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    [Google Scholar]
  18. Di SantoP. MathewR. JungR.G. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: A subgroup analysis of the DOREMI trial.Crit. Care202125128910.1186/s13054‑021‑03706‑2 34376218
     [Google Scholar]
  19. TamakiY. YakuH. MorimotoT. Lower in‐hospital mortality with beta‐blocker use at admission in patients with acute decompensated heart failure.J. Am. Heart Assoc.20211013e02001210.1161/JAHA.120.020012 34180244
     [Google Scholar]
  20. Abi KhalilC. SulaimanK. MahfoudZ. Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East.BMJ Open201777e01491510.1136/bmjopen‑2016‑014915 28694343
     [Google Scholar]
  21. MiróÒ. MüllerC. Martín-SánchezF.J. BETAWIN-AHF study: Effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.Clin. Res. Cardiol.2016105121021102910.1007/s00392‑016‑1014‑9 27379611
     [Google Scholar]
  22. Abi KhalilC. SulaimanK. AsaadN. Beta-blockers and cardiovascular outcomes in acute heart failure with a history of coronary artery disease and an ejection fraction ≥ 40%.Curr. Vasc. Pharmacol.202018664465110.2174/1570161118666191231114203 31889498
     [Google Scholar]
  23. WuW.T. ChuC.Y. HsuP.C. Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study.PLoS One20181310e020544010.1371/journal.pone.0205440 30308032
     [Google Scholar]
  24. KadoglouN.P. ParissisJ. KaravidasA. KanonidisI. TrivellaM. Assessment of acute heart failure prognosis: The promising role of prognostic models and biomarkers.Heart Fail. Rev.202227265566310.1007/s10741‑021‑10122‑9 34036472
     [Google Scholar]
  25. GayatE. ArrigoM. LittnerovaS. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: A propensity‐score matched study.Eur. J. Heart Fail.201820234535410.1002/ejhf.932 28849606
     [Google Scholar]
  26. Marin-NetoJ.A. SimõesM.V. The role of the sympathetic nervous system in heart failure.2014Available from: https://socesp.org.br/revista/pdfjs/web/viewer.html?arquivo=3697328721544615069pdfpt24(2)-revista.pdf&edicoes=1
    [Google Scholar]
  27. KotechaD. FlatherM.D. AltmanD.G. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure.J. Am. Coll. Cardiol.201769242885289610.1016/j.jacc.2017.04.001 28467883
     [Google Scholar]
  28. TakahamaH. YokoyamaH. KadaA. The extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.J. Cardiol.2013611586410.1016/j.jjcc.2012.08.014 23165149
     [Google Scholar]
  29. LopatinY.M. CowieM.R. GrebennikovaA.A. Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program.Int. J. Cardiol.201826011311710.1016/j.ijcard.2017.12.093 29622423
     [Google Scholar]
  30. MotiejunaiteJ. AmarL. Vidal-PetiotE. Adrenergic receptors and cardiovascular effects of catecholamines.Ann. Endocrinol. 2021823-419319710.1016/j.ando.2020.03.012 32473788
     [Google Scholar]
  31. AlbuquerqueF.N. BrandãoA.A. SilvaD.A. Ser49Gly beta1-adrenergic receptor genetic polymorphism as a death predictor in brazilian patients with heart failure.Arq. Bras. Cardiol.2020114461662410.36660/abc.20190187 32491001
     [Google Scholar]
  32. SilvermanD.N. PlanteT.B. InfeldM. Association of β-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction.JAMA Netw. Open2019212e191659810.1001/jamanetworkopen.2019.16598 31800067
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X291307240902071924
Loading
The Impact of Beta-Blocker Maintenance on Decompensated Heart Failure: A Systematic Review and Meta-Analysis
Curr. Cardiol. Rev. 21, E1573403X291307 (2025); https://doi.org/10.2174/011573403X291307240902071924
/content/journals/ccr/10.2174/011573403X291307240902071924
/content/journals/ccr/10.2174/011573403X291307240902071924
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): beta blockers; beta-adrenergic antagonists; Heart failure; hospitalization; mortality; systolic blood pressure

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test